“Global Antifungal Drugs market set to grow to $17bn by 2024” says new Visiongain report

04 June 2019
Pharma

Visiongain has published a new pharma report Global Antifungal Drugs Market Forecast 2019-2029: Azoles, Echinocandins, Polyenes, Allylamines, Voriconazole, Posaconazole, Clotrimazole, Isavuconazole, Fluconazole, Caspofungin, Micagunfin, Amphotericin, Lamisil, Dermatophytosis, Aspergillosis, Candidiasis.

The global antifungal drugs market is estimated to have reached $14bn in 2018 and is expected to grow at a CAGR of 3.8% during the forecast period. In 2018, the global antifungal drugs market was dominated by Azoles.

This report profiled the selected companies: Abbott Laboratories, Bayer AG, Enzon Pharmaceuticals, Inc., Gilead Sciences, Inc., GlaxoSmithKline, Kramer Laboratories, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Sanofi S.A. and others.

The lead analyst commented that "Market penetration and adoption of new technologies entering the market for antifungal drugs will be crucial for market growth.

The antifungal drugs market is mainly driven by the incidence and prevalence rate of antifungal infections. Moreover, cost-effective products, growing population of immunocompromised individuals and minimal side-effects are other factors that will drive market growth. However, antifungal drugs market has some restraints such as the presence of alternative therapies."

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain publishes Constipation Nutraceuticals Market Report 2020-2030

Nutraceuticals are the products that provide medicinal and health benefits to the people. These products provide additional nutritional value to the foodstuff.

01 June 2020

Read

“Precision Medicine Market is Poised to Surpass US$67 billion in 2020” says new Visiongain report

Visiongain anticipates that the global precision medicine market is projected to witness a CAGR of 12% over the forecast period from 2020 to 2030. The global precision medicine market is anticipated to surpass US$ 67 billion in 2020 and is further projected to surpass US$ 200 billion in 2030.

27 May 2020

Read

Visiongain publishes Colon Targeting Drug Delivery Market Report 2020-2030

The global colon targeting drug delivery market is projected to grow at a CAGR of 8.07% in the first half of the forecast period. Visiongain anticipate that the global market will witness a CAGR of 9.23% during the forecast period 2020 to 2030.

27 May 2020

Read

“The global automation in biopharma market is estimated to reach USD 1.23 billion by 2025” says new Visiongain report

The automation in biopharma industry market is estimated to grow at a CAGR of 4.3% over the forecast period.

22 May 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever